The current use and evolving landscape of nutraceuticals.


Journal

Pharmacological research
ISSN: 1096-1186
Titre abrégé: Pharmacol Res
Pays: Netherlands
ID NLM: 8907422

Informations de publication

Date de publication:
01 2022
Historique:
received: 05 10 2021
revised: 21 11 2021
accepted: 22 11 2021
pubmed: 27 11 2021
medline: 20 1 2022
entrez: 26 11 2021
Statut: ppublish

Résumé

The nutraceutical market is currently a high-impact multi-billion-dollar industry, and it is anticipated to grow rapidly over the next decade. Nutraceuticals comprise diverse food-derived product categories that have become widespread due to increased consumer awareness of potential health benefits and the need for improved wellness. This targeted review is designed to identify the current global trends, market opportunities, and regulations that drive the nutraceutical industry. Safety and efficacy concerns are also explored with a view to highlighting areas that necessitate further research and oversight. Key drivers of the nutraceutical market include aging populations, consumer awareness, consumer lifestyle, increasing cost of healthcare, and marketing channels. Although some nutraceuticals hold promising preventive and therapeutic opportunities, there is a lack of a universal definition and regulatory framework among countries. Moreover, there is a lack of adequate evidence for their efficacy, safety, and effectiveness, which was even further highlighted during the ongoing coronavirus pandemic. Future prospective epidemiological studies can delineate the health impact of nutraceuticals and help set the scientific basis and rationale foundation for clinical trials, reducing the time and cost of trials themselves. Together, an understanding of the key drivers of the nutraceutical market alongside a consistent and well-defined regulatory framework will provide further opportunities for growth, expansion, and segmentation of nutraceuticals applications.

Identifiants

pubmed: 34826602
pii: S1043-6618(21)00585-5
doi: 10.1016/j.phrs.2021.106001
pii:
doi:

Substances chimiques

Biological Products 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

106001

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Avijeet S Chopra (AS)

Manticore Consulting Group, Bethesda, MD, United States.

Ronan Lordan (R)

Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States. Electronic address: Ronan.Lordan@Pennmedicine.upenn.edu.

Olaf K Horbańczuk (OK)

Warsaw University of Life Sciences, Faculty of Human Nutrition, Nowoursynowska 159 C, 02-776 Warsaw, Poland. Electronic address: olaf_horbanczuk@sggw.edu.pl.

Atanas G Atanasov (AG)

Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, 05-552 Jastrzebiec, Poland; Ludwig Boltzmann Institute for Digital Health and Patient Safety, Medical University of Vienna, Spitalgasse 23, 1090 Vienna, Austria. Electronic address: Atanas.Atanasov@dhps.lbg.ac.at.

Ishveen Chopra (I)

Manticore Consulting Group, Bethesda, MD, United States.

Jarosław O Horbańczuk (JO)

Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, 05-552 Jastrzebiec, Poland.

Artur Jóźwik (A)

Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, 05-552 Jastrzebiec, Poland.

Linfang Huang (L)

Institute of Medicinal Plant Development (IMPLAD), Peking Union Medical College, Chinese Academy of Medical Sciences (CAMS), Beijing, PR China.

Vasil Pirgozliev (V)

National Institute of Poultry Husbandry, Harper Adams University, Shropshire TF10 8NB, UK.

Maciej Banach (M)

Department of Preventative Cardiology and Lipidology, Medical University of Lodz, Lodz, Poland.

Maurizio Battino (M)

Department of Clinical Sciences, Università Politecnica delle Marche, Ancona, Italy; International Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang, PR China.

Nicolas Arkells (N)

Manticore Consulting Group, Scottsdale, AZ, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH